PNEUMOXYTOL® Nebulizer Ampoules

PNEUMOXYTOL® is indicated for the recovery and maintenance of the natural physiology of the mucosa and the tissue of the respiratory tract affected by chronic bronchial inflammation, such as asthma and chronic obstructive pulmonary disease (COPD). Promotes recovery and maintenance of the natural physiology of the mucosa and the tissue of the respiratory tract affected by environmental pollutants, cigarette smoke or other chemicals. PNEUMOXYTOL® is indicated for the treatment of symptoms relating to illnesses of the upper airways including: acute as well as chronic oropharyngitis, hoarseness and cough caused by post-viral irritation, cold and flu, aftermath of ENT operations. Reduction in respiratory distress syndrome in premature babies PNEUMOXYTOL® is indicated for adults and children. It does not replace but rather supplements other therapeutic treatments.

Composition

Each ampoule of 3 ml contains: Myo-inositol 400 mg, sodium chloride 27 mg, purified water q.s. to 3 ml.

Recommended Posology

It is recommended to take 1 x 3 ml ampoule or as instructed by your doctor, up to a maximum of 3 ampoules per day. Do not exceed the recommended dose.

Additional information

It is a CE1370 medica device. Please read the warnings or instructions for use. 
Translation of the message authorized by the Ministry of Health: 23/01/2026